30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q14 Revenue: RTI Surgical

$50.7MM, +75%

  • Spine $21.3MM, +90%
  • Sports Medicine $11.4MM, -2%
  • Bone Graft Substitutes/General Orthopaedic $9.0MM, +50%
  • Ortho Fixation $8.8MM


  • Launched Streamline OCT System, designed to promote fusion of the occipto-cervico-thoracic spine, with high-angle pedicle screw that offers 60 degrees of angulation in any direction
  • Sports Medicine decrease attributed to unfavorable comps; account recapture and new account development strong in 1H14
  • 1st implantation of map3 Cellular Allogeneic Bone Graft Strips, in ALIF procedure; will launch before year-end
  • 2014 new products still to come in spine, biologics, sports medicine
  • Significant uptake in conversions in spine, both U.S. and ex-U.S.
  • Bullish on spine, not seeing pricing degradation, procedures are steady